Abstract:Language impairments caused by stroke (post-stroke aphasia, PSA) and neurodegeneration (primary progressive aphasia, PPA) have overlapping symptomatology, nomenclature and are classically divided into categorical subtypes. Surprisingly, PPA and PSA have rarely been directly compared in detail. Rather, previous studies have compared certain subtypes (e.g. semantic variants) or have focused on a specific cognitive/linguistic task (e.g. reading). This study assessed a large range of linguistic and cognitive tasks… Show more
“…By evaluating a large cohort of patients suffering from stroke, neurodegenerative, and post-resective aphasia, we have provided a two-dimensional framework that can visualize language impairment across a variety of disease etiologies. While the language tool assessment shared across three cohorts highlights the similarities of aphasia phenotypes across disease etiologies, as with prior dimensionality reduction studies ( 22 ), the proposed framework using only two dimensions also provides sufficient granularity to preserve clinical classifications across all cohorts. This visual method of characterizing an aphasia phenotype provides a simplified and intuitive method of rapidly assessing aphasia phenotypes across populations and time.…”
Section: Discussionmentioning
confidence: 97%
“…The behavioral similarity mirrors the neuroanatomical similarity, in which peak atrophy for patients with nfvPPA localizes to the left posterior inferior frontal gyrus and adjacent areas ( 3 ). Investigation at higher dimensions or with more detailed behavioral assessments would enable discernment of behavioral differences ( 22 ). For instance, studies of nfvPPA have shown that grammar and fluency can be dissociated; case examples of patients with nfvPPA were found to have near normal fluency but impaired grammar and vice versa.…”
Section: Discussionmentioning
confidence: 99%
“…Other studies have attempted to subtype PPA variants on a two dimensional template comprised of grammaticality and word comprehension, based on the clinical identification of orthogonal tasks for subtyping ( 36 , 37 ). Only one prior study, Ingram et al ( 22 ), proposed a multidimensional cross-cohort platform, composed of four dimensions. As compared to Ingram et al ( 22 ), this study focused on the development of a two dimensional platform using a screening aphasia battery to provide a single framework for characterizing phenotypes.…”
Section: Discussionmentioning
confidence: 99%
“…Only one prior study, Ingram et al ( 22 ), proposed a multidimensional cross-cohort platform, composed of four dimensions. As compared to Ingram et al ( 22 ), this study focused on the development of a two dimensional platform using a screening aphasia battery to provide a single framework for characterizing phenotypes. Because this study employed two native dimensions rather than a four factor rotated solution ( 22 ), the interpretations of the dimensions were distinct.…”
Section: Discussionmentioning
confidence: 99%
“…Second, using this framework, we demonstrate that disease phenotypes can be visually tracked over time. Recent efforts ( 22 ) have demonstrated the feasibility of comparing across patient cohorts using dimensionality reduction techniques; we propose an alternative two-dimensional platform and demonstrate the feasibility of tracking disease attributes over time. Ultimately, this method, combined with more detailed language evaluations shared across cohorts may allow for the interdisciplinary study of complex language networks, by focusing on their similarities rather than their differences.…”
Aphasia classifications and specialized language batteries differ across the fields of neurodegenerative disorders and lesional brain injuries, resulting in difficult comparisons of language deficits across etiologies. In this study, we present a simplified framework, in which a widely-used aphasia battery captures clinical clusters across disease etiologies and provides a quantitative and visual method to characterize and track patients over time. The framework is used to evaluate populations representing three disease etiologies: stroke, primary progressive aphasia (PPA), and post-operative aphasia. A total of 330 patients across three populations with cerebral injury leading to aphasia were investigated, including 76 patients with stroke, 107 patients meeting criteria for PPA, and 147 patients following left hemispheric resective surgery. Western Aphasia Battery (WAB) measures (Information Content, Fluency, answering Yes/No questions, Auditory Word Recognition, Sequential Commands, and Repetition) were collected across the three populations and analyzed to develop a multi-dimensional aphasia model using dimensionality reduction techniques. Two orthogonal dimensions were found to explain 87% of the variance across aphasia phenotypes and three disease etiologies. The first dimension reflects shared weighting across aphasia subscores and correlated with aphasia severity. The second dimension incorporates fluency and comprehension, thereby separating Wernicke's from Broca's aphasia, and the non-fluent/agrammatic from semantic PPA variants. Clusters representing clinical classifications, including late PPA presentations, were preserved within the two-dimensional space. Early PPA presentations were not classifiable, as specialized batteries are needed for phenotyping. Longitudinal data was further used to visualize the trajectory of aphasias during recovery or disease progression, including the rapid recovery of post-operative aphasic patients. This method has implications for the conceptualization of aphasia as a spectrum disorder across different disease etiology and may serve as a framework to track the trajectories of aphasia progression and recovery.
“…By evaluating a large cohort of patients suffering from stroke, neurodegenerative, and post-resective aphasia, we have provided a two-dimensional framework that can visualize language impairment across a variety of disease etiologies. While the language tool assessment shared across three cohorts highlights the similarities of aphasia phenotypes across disease etiologies, as with prior dimensionality reduction studies ( 22 ), the proposed framework using only two dimensions also provides sufficient granularity to preserve clinical classifications across all cohorts. This visual method of characterizing an aphasia phenotype provides a simplified and intuitive method of rapidly assessing aphasia phenotypes across populations and time.…”
Section: Discussionmentioning
confidence: 97%
“…The behavioral similarity mirrors the neuroanatomical similarity, in which peak atrophy for patients with nfvPPA localizes to the left posterior inferior frontal gyrus and adjacent areas ( 3 ). Investigation at higher dimensions or with more detailed behavioral assessments would enable discernment of behavioral differences ( 22 ). For instance, studies of nfvPPA have shown that grammar and fluency can be dissociated; case examples of patients with nfvPPA were found to have near normal fluency but impaired grammar and vice versa.…”
Section: Discussionmentioning
confidence: 99%
“…Other studies have attempted to subtype PPA variants on a two dimensional template comprised of grammaticality and word comprehension, based on the clinical identification of orthogonal tasks for subtyping ( 36 , 37 ). Only one prior study, Ingram et al ( 22 ), proposed a multidimensional cross-cohort platform, composed of four dimensions. As compared to Ingram et al ( 22 ), this study focused on the development of a two dimensional platform using a screening aphasia battery to provide a single framework for characterizing phenotypes.…”
Section: Discussionmentioning
confidence: 99%
“…Only one prior study, Ingram et al ( 22 ), proposed a multidimensional cross-cohort platform, composed of four dimensions. As compared to Ingram et al ( 22 ), this study focused on the development of a two dimensional platform using a screening aphasia battery to provide a single framework for characterizing phenotypes. Because this study employed two native dimensions rather than a four factor rotated solution ( 22 ), the interpretations of the dimensions were distinct.…”
Section: Discussionmentioning
confidence: 99%
“…Second, using this framework, we demonstrate that disease phenotypes can be visually tracked over time. Recent efforts ( 22 ) have demonstrated the feasibility of comparing across patient cohorts using dimensionality reduction techniques; we propose an alternative two-dimensional platform and demonstrate the feasibility of tracking disease attributes over time. Ultimately, this method, combined with more detailed language evaluations shared across cohorts may allow for the interdisciplinary study of complex language networks, by focusing on their similarities rather than their differences.…”
Aphasia classifications and specialized language batteries differ across the fields of neurodegenerative disorders and lesional brain injuries, resulting in difficult comparisons of language deficits across etiologies. In this study, we present a simplified framework, in which a widely-used aphasia battery captures clinical clusters across disease etiologies and provides a quantitative and visual method to characterize and track patients over time. The framework is used to evaluate populations representing three disease etiologies: stroke, primary progressive aphasia (PPA), and post-operative aphasia. A total of 330 patients across three populations with cerebral injury leading to aphasia were investigated, including 76 patients with stroke, 107 patients meeting criteria for PPA, and 147 patients following left hemispheric resective surgery. Western Aphasia Battery (WAB) measures (Information Content, Fluency, answering Yes/No questions, Auditory Word Recognition, Sequential Commands, and Repetition) were collected across the three populations and analyzed to develop a multi-dimensional aphasia model using dimensionality reduction techniques. Two orthogonal dimensions were found to explain 87% of the variance across aphasia phenotypes and three disease etiologies. The first dimension reflects shared weighting across aphasia subscores and correlated with aphasia severity. The second dimension incorporates fluency and comprehension, thereby separating Wernicke's from Broca's aphasia, and the non-fluent/agrammatic from semantic PPA variants. Clusters representing clinical classifications, including late PPA presentations, were preserved within the two-dimensional space. Early PPA presentations were not classifiable, as specialized batteries are needed for phenotyping. Longitudinal data was further used to visualize the trajectory of aphasias during recovery or disease progression, including the rapid recovery of post-operative aphasic patients. This method has implications for the conceptualization of aphasia as a spectrum disorder across different disease etiology and may serve as a framework to track the trajectories of aphasia progression and recovery.
INTRODUCTIONHere we set out to create a symptom‐led staging system for the canonical semantic and non‐fluent/agrammatic variants of primary progressive aphasia (PPA), which present unique diagnostic and management challenges not well captured by functional scales developed for Alzheimer's disease and other dementias.METHODSAn international PPA caregiver cohort was surveyed on symptom development under six provisional clinical stages and feedback was analyzed using a mixed‐methods sequential explanatory design.RESULTSBoth PPA syndromes were characterized by initial communication dysfunction and non‐verbal behavioral changes, with increasing syndromic convergence and functional dependency at later stages. Milestone symptoms were distilled to create a prototypical progression and severity scale of functional impairment: the PPA Progression Planning Aid (“PPA‐Squared”).DISCUSSIONThis work introduces a symptom‐led staging scheme and functional scale for semantic and non‐fluent/agrammatic variants of PPA. Our findings have implications for diagnostic and care pathway guidelines, trial design, and personalized prognosis and treatment for PPA.Highlights
We introduce new symptom‐led perspectives on primary progressive aphasia (PPA).
The focus is on non‐fluent/agrammatic (nfvPPA) and semantic (svPPA) variants.
Foregrounding of early and non‐verbal features of PPA and clinical trajectories is featured.
We introduce a symptom‐led staging scheme for PPA.
We propose a prototype for a functional impairment scale, the PPA Progression Planning Aid.
Here, we review recent progress in the diagnosis and management of primary progressive aphasia—the language-led dementias. We pose six key unanswered questions that challenge current assumptions and highlight the unresolved difficulties that surround these diseases. How many syndromes of primary progressive aphasia are there—and is syndromic diagnosis even useful? Are these truly ‘language-led’ dementias? How can we diagnose (and track) primary progressive aphasia better? Can brain pathology be predicted in these diseases? What is their core pathophysiology? In addition, how can primary progressive aphasia best be treated? We propose that pathophysiological mechanisms linking proteinopathies to phenotypes may help resolve the clinical complexity of primary progressive aphasia, and may suggest novel diagnostic tools and markers and guide the deployment of effective therapies.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.